Table 2.
Comparison of patients between high/moderate (DAS 28 > 3.2) and low disease activity (DAS 28 ≤ 3.2)
| High/moderate disease activity (n = 27) | Low disease activity (n = 10) | P | |
|---|---|---|---|
| Age (years) | 48.11 ±8.38 | 51.20 ±4.70 | 0.281 |
| Female/Male | 20/7 | 9/1 | 0.296 |
| Duration of the disease (years) | 11.63 ±6.49 | 16.00 ±6.73 | 0.080 |
| Rheumatoid factor (IU/ml) | 118.53 ±140.31 | 46.64 ±52.35 | 0.126 |
| Anti-cyclic citrullinated peptide (IU/ml) | 275.74.94 ±289.41 | 312.52 ±355.19 | 0.749 |
| ESR (mm/h) | 30.56 ±16.24 | 20.20 ±11.78 | 0.075 |
| C-reactive protein (g/dl) | 25.36 ±39.12 | 4.73 ±3.23 | 0.108 |
| Serum LCN-2 (ng/ml) | 821.38 ±536.13 | 756.33 ±448.30 | 0.735 |
ESR – erythrocyte sedimentation rate, LCN-2 – lipocalin 2